| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
-hydroxylase/17,20 lyase) in Human Adrenal NCI-H295A Cells
Department of Pediatrics and The Metabolic Research Unit, University of California San Francisco, San Francisco, California 94143-0978
Address all correspondence and request for reprints to: Professor Walter L. Miller, Department of Pediatrics, Building MR IV, Room 209, University of California San Francisco, San Francisco, California 94143-0978.
Cytochrome P450c17 catalyzes steroid 17
-hydroxylase and
17,20 lyase activities, which are required for the biosynthesis of
cortisol and sex steroids. Human P450c17 is expressed in a
cAMP-responsive, cell-specific, developmentally programmed fashion, but
little is known about its transcriptional regulation. Expression of
deletion mutants of up to 2,500 bp of human 5'-flanking DNA in human
adrenal NCI-H295A cells indicated that most regulatory activity was
confined to the first 227 bp. Deoxyribonuclease I footprinting of the
proximal promoter identified the TATA box, an steroidogenic factor-1
site, and three previously uncharacterized sites at -107/85, at
-178/-152, and at -220/-185. EMSAs and methylation interference
assays suggested that the -107/-85 site and the -178/-152 site bind
members of the NF-1 (nuclear factor-1) family of transcription factors.
An NF-1 consensus sequence generated similar DNA/protein complexes, and
antibodies against NF-1C2/CTF2 supershifted the complexes formed by the
-107/-85 site, the -178/-152 site, and the NF-1 consensus site.
Western blots of nuclear extracts from NCI-H295A cells probed with this
NF-1 antiserum identified two NF-1 isoforms between 50 and 55 kDa. The
presence of NF-1C2 (CTF2) and CTF5 in NCI-H295A cells was demonstrated
by RT-PCR and sequencing. Mutation of both the -107/-85 and the
-178/-152 NF-1 sites reduced basal transcription by half. Supershift
assays showed that the ubiquitous proteins Sp1 and Sp3 both bind
to the -227/-184 region, and that mutation of their binding sites
reduced transcription by 75%. Mutation of the Sp1/Sp3 site plus the
two NF-1 sites eliminated almost all detectable transcription. Thus,
Sp1 and Sp3 binding to the -227/-184 site and NF-1C proteins binding
to the -107/-85 and the -178/-152 sites are crucial for adrenal
transcription of the human gene for P450c17.
This article has been cited by other articles:
![]() |
E. Samandari, P. Kempna, J.-M. Nuoffer, G. Hofer, P. E Mullis, and C. E Fluck Human adrenal corticocarcinoma NCI-H295R cells produce more androgens than NCI-H295A cells and differ in 3{beta}-hydroxysteroid dehydrogenase type 2 and 17,20 lyase activities J. Endocrinol., December 1, 2007; 195(3): 459 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Kuhl, S. M. Ross, and K. W. Gaido CCAAT/Enhancer Binding Protein {beta}, But Not Steroidogenic Factor-1, Modulates the Phthalate-Induced Dysregulation of Rat Fetal Testicular Steroidogenesis Endocrinology, December 1, 2007; 148(12): 5851 - 5864. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Mellon, S. R. Bair, C. Depoix, J.-L. Vigne, N. B. Hecht, and P. B. Brake Translin Coactivates Steroidogenic Factor-1-Stimulated Transcription Mol. Endocrinol., January 1, 2007; 21(1): 89 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Jasienska, M. Kapiszewska, P. T. Ellison, M. Kalemba-Drozdz, I. Nenko, I. Thune, and A. Ziomkiewicz CYP17 Genotypes Differ in Salivary 17-{beta} Estradiol Levels: A Study Based on Hormonal Profiles from Entire Menstrual Cycles. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2131 - 2135. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Huang, A. Dardis, and W. L. Miller Regulation of Cytochrome b5 Gene Transcription by Sp3, GATA-6, and Steroidogenic Factor 1 in Human Adrenal NCI-H295A Cells Mol. Endocrinol., August 1, 2005; 19(8): 2020 - 2034. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Risk, A. Shehu, J. Mao, C. O. Stocco, L. T. Goldsmith, J. M. Bowen-Shauver, and G. Gibori Cloning and Characterization of a 5' Regulatory Region of the Prolactin Receptor-Associated Protein/17{beta} Hydroxysteroid Dehydrogenase 7 Gene Endocrinology, June 1, 2005; 146(6): 2807 - 2816. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Wickenheisser, V. L. Nelson-DeGrave, and J. M. McAllister Dysregulation of Cytochrome P450 17{alpha}-Hydroxylase Messenger Ribonucleic Acid Stability in Theca Cells Isolated from Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1720 - 1727. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Kok, N. C. Onland-Moret, K. M. van Asselt, C. H. van Gils, Y. T. van der Schouw, D. E. Grobbee, and P. H.M. Peeters No association of estrogen receptor {alpha} and cytochrome P450c17{alpha} polymorphisms with age at menopause in a Dutch cohort Hum. Reprod., February 1, 2005; 20(2): 536 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Fluck and W. L. Miller GATA-4 and GATA-6 Modulate Tissue-Specific Transcription of the Human Gene for P450c17 by Direct Interaction with Sp1 Mol. Endocrinol., May 1, 2004; 18(5): 1144 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baldwin, L. Pirisi, and K. E. Creek NFI-Ski Interactions Mediate Transforming Growth Factor {beta} Modulation of Human Papillomavirus Type 16 Early Gene Expression J. Virol., April 15, 2004; 78(8): 3953 - 3964. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Wickenheisser, V. L. Nelson-DeGrave, P. G. Quinn, and J. M. McAllister Increased Cytochrome P450 17{alpha}-Hydroxylase Promoter Function in Theca Cells Isolated from Patients with Polycystic Ovary Syndrome Involves Nuclear Factor-1 Mol. Endocrinol., March 1, 2004; 18(3): 588 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Costa-Santos, C. E. Kater, and R. J. Auchus Two Prevalent CYP17 Mutations and Genotype-Phenotype Correlations in 24 Brazilian Patients with 17-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 49 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ntais, A. Polycarpou, and J. P. A. Ioannidis Association of the CYP17 Gene Polymorphism with the Risk of Prostate Cancer: A Meta-Analysis Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 120 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Phillips, J. Bailey, S. C. Robson, and G. N. Europe-Finner Differential Expression of the Adenylyl Cyclase-Stimulatory Guanosine Triphosphate-Binding Protein Gs{alpha} in the Human Myometrium during Pregnancy and Labor Involves Transcriptional Regulation by Cyclic Adenosine 3',5'-Monophosphate and Binding of Phosphorylated Nuclear Proteins to Multiple GC Boxes within the Promoter J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5675 - 5685. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Laurich, A. M. Trbovich, F. H. O'Neill, C. P. Houk, P. M. Sluss, A. H. Payne, P. K. Donahoe, and J. Teixeira Mullerian Inhibiting Substance Blocks the Protein Kinase A-Induced Expression of Cytochrome P450 17{alpha}-Hydroxylase/C17-20 Lyase mRNA in a Mouse Leydig Cell Line Independent of cAMP Responsive Element Binding Protein Phosphorylation Endocrinology, September 1, 2002; 143(9): 3351 - 3360. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Sewer, V. Q. Nguyen, C.-J. Huang, P. W. Tucker, N. Kagawa, and M. R. Waterman Transcriptional Activation of Human CYP17 in H295R Adrenocortical Cells Depends on Complex Formation among p54nrb/NonO, Protein-Associated Splicing Factor, and SF-1, a Complex That Also Participates in Repression of Transcription Endocrinology, April 1, 2002; 143(4): 1280 - 1290. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |